22

2024

-

11

Yichang City Pharmaceutical and Health Chamber of Commerce warmly celebrates the successful completion of the 10th anniversary and the commissioning ceremony of the second phase project of Hubei Guangchen Pharmaceutical Co., Ltd.

Author:

https://mp.weixin.qq.com/s/94DkRA7usZmsqTS9reh3zg

Related News

Hubei Guangchen Pharmaceutical held a grand commendation conference for the year 2024.

Hubei Guangchen Pharmaceutical held a grand commendation conference for the year 2024.

2025-02-05

On January 25, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. held a grand award ceremony to honor the outstanding employees and outstanding teams of the year 2024.

Hubei Guangchen Pharmaceutical Co., Ltd. held a grand annual work summary meeting for 2024.

Hubei Guangchen Pharmaceutical Co., Ltd. held a grand annual work summary meeting for 2024.

2025-02-03

On January 18, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. held a grand annual work summary meeting for 2024.

Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

2024-12-31

Experts from the Hubei Provincial Chemical Weapons Prohibition Office visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

General Manager Chen Shaoyan and his team visited the School of Biology and Pharmacy at Three Gorges University.

General Manager Chen Shaoyan and his team visited the School of Biology and Pharmacy at Three Gorges University.

2024-12-31

On December 27, 2024, Chen Shaoyan, the general manager of Hubei Guangchen Pharmaceutical Co., Ltd., and his team visited the School of Biology and Pharmacy at Three Gorges University. They had in-depth discussions with Dean Zhou Haifeng and his research team members about further deepening school-enterprise cooperation and jointly building research platforms.